Desonide
Desonide (Desonide), which has been used since the 1970's, is weak locally. It is mainly used for treatment of adults and children. The safety is quite high, Verdeso It is a trademark of Foam, and it is available in the form of cream, cartilage, lotion, etc. In the United States, it is classified as adrenocortical hormone of the second weak group of VIs.
Desonide - - Substance name by
(1 S , 2 _ S , 4 _ R , 8 S , 9 S , 11 S , 12 S , 13 _ R _ ) -11-hydroxy-8- (2-hydroxyacetyl) -6,6,9,13-tetramethyl-5,7-dioxapentacyclo [10.8.0.02, 9.04, 8,13,18] icosa-14, 17-dien-16- one
Clinical data | Desowen | | |
- US:
*
| topical Identification
| | () () | CID: | | | | | | Alias | (11β, 16α) -11,21-Dihydroxy-16,17 - [(1-methylethylidene) bis (oxy)] - pregna-1,4-diene-3,20-dione Chemical data | 24326 | 416.507 g / mol
-
C = C \ 1 \ C = C / [C @] 2 (/ C (= C / 1) CC [C @ H] 3 [C @ H] 4 [C @] (C [C @ H] C) C (═O) CO) C) C (═O) ═O) [C @ H] 23)
-
InChI = 1 S / C 24 H 32 O 6 / c 1 - 21 (2) 29 - 19 - 10 - 16 - 15 - 6 - 5 - 13 - 9 - 14 (26) 7 - 8 - 22 (13, 3) 20 (15) 17 (27) 11-23 (16, 4) 24 (19, 30-21) 18 (28) 12-25 / h7-9, 15-17, 19-20, 25, 27H, 5-6, 10-12 H2 , 1-4 H 3 / t 15 -, 16 -, 17 -, 19 +, 20 +, 22 -, 23 -, 24 + / m 0 / s 1
-
Key: WBGKWQHBNHJJPZ-LECWWXJVSA-N
Source
1. *Wong, Vicky Kwan; Brian Fuchs, (2004). "Overview on desonide 0.05%: a clinical safety profile". Journal of Drugs in Dermatology: JDD *3(4): 393 - 7 .
Acquired from ""
- [US]: USA
Post Date : 2018-02-07 04:30
This article is taken from the Japanese Wikipedia Desonide
This article is distributed by cc-by-sa or GFDL license in accordance with the provisions of Wikipedia.
In addition, This site is simply not responsible for any show is only by translating the writings of foreign licenses that are compatible with CC-BY-SA license information.
0 개의 댓글:
댓글 쓰기